Unicycive Therapeutics
UNCY
34 hedge funds and large institutions have $47M invested in Unicycive Therapeutics in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
72% more capital invested
Capital invested by funds: $27.4M → $47M (+$19.6M)
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
13% more funds holding
Funds holding: 30 → 34 (+4)
2.31% more ownership
Funds ownership: 35.59% → 37.9% (+2.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$5.42M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.16M |
| 3 |
CF
Cantor Fitzgerald
New York
|
+$1.07M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$692K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$532K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
-$331K |
| 2 |
Goldman Sachs
New York
|
-$197K |
| 3 |
Citigroup
New York
|
-$34.5K |
| 4 |
CPIG
Chicago Partners Investment Group
Chicago,
Illinois
|
-$24.3K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$12.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SS
26
SBI Securities
Tokyo,
Japan
| $3.22K | -$11 | -2 | -0.4% |
|
27
Rockefeller Capital Management
New York
| $2.88K | – | – | – |
|
|
TFM
28
TFC Financial Management
Boston,
Massachusetts
| $1.73K | – | – | – |
|
|
29
Citigroup
New York
| $1.32K | -$34.5K | -6,464 | -97% |
|
30
Bank of America
Charlotte,
North Carolina
| $877 | -$3.6K | -675 | -82% |
|
|
HI
31
Harbour Investments
Madison,
Wisconsin
| $577 | – | – | – |
|
32
Barclays
London,
United Kingdom
| $462 | – | – | – |
|
|
BWL
33
Bogart Wealth LLC
Mclean,
Virginia
| $35 | – | – | – |
|
|
DB
34
Danske Bank
Copenhagen K,
Denmark
| $6 | – | – | – |
|
|
35
Goldman Sachs
New York
| – | -$197K | -45,200 | Closed |
|
|
FFO
36
Fortitude Family Office
Scottsdale,
Arizona
| – | -$467 | -107 | Closed |
|
UNCY Hedge Fund Activity: Q4 2025 in Review
34 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Unicycive Therapeutics (UNCY) for Q4 2025, worth a combined $47M — up 72% from $27.4M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new UNCY positions and 2 closed out — a net gain of 5 holders — while 8 added to existing stakes and 6 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $5.42M. The largest seller was Squarepoint, cutting an estimated $331K.
- 34 institutional investors held Unicycive Therapeutics (UNCY) as of Q4 2025, up from 30 in Q3 2025.
- Funds reported $47M of Unicycive Therapeutics stock for Q4 2025, up 72% quarter-over-quarter.
- 7 funds opened new Unicycive Therapeutics positions in Q4 2025 and 2 closed out, a net change of +5 holders.
- The largest Unicycive Therapeutics buyer in Q4 2025 was Millennium Management, an estimated $5.42M added.
- The largest Unicycive Therapeutics seller in Q4 2025 was Squarepoint, an estimated $331K sold.
Based on aggregated 13F filings for Q4 2025.